A portrait of tissue phosphoprotein stability in the clinical tissue procurement process.

Mol Cell Proteomics 2008 Oct 30;7(10):1998-2018. Epub 2008 Jul 30.

Center for Applied Proteomics and Molecular Medicine, George Mason University, Manassas, Virginia 20110, USA.

Little is known about the preanalytical fluctuations of phosphoproteins during tissue procurement for molecular profiling. This information is crucial to establish guidelines for the reliable measurement of these analytes. To develop phosphoprotein profiles of tissue subjected to the trauma of excision, we measured the fidelity of 53 signal pathway phosphoproteins over time in tissue specimens procured in a community clinical practice. This information provides strategies for potential surrogate markers of stability and the design of phosphoprotein preservative/fixation solutions. Eleven different specimen collection time course experiments revealed augmentation (+/-20% from the time 0 sample) of signal pathway phosphoprotein levels as well as decreases over time independent of tissue type, post-translational modification, and protein subcellular location (tissues included breast, colon, lung, ovary, and uterus (endometrium/myometrium) and metastatic melanoma). Comparison across tissue specimens showed an >20% decrease of protein kinase B (AKT) Ser-473 (p < 0.002) and myristoylated alanine-rich C-kinase substrate protein Ser-152/156 (p < 0.0001) within the first 90-min postexcision. Proteins in apoptotic (cleaved caspase-3 Asp-175 (p < 0.001)), proliferation/survival/hypoxia (IRS-1 Ser-612 (p < 0.0003), AMP-activated protein kinase beta Ser-108 (p < 0.005), ERK Thr-202/Tyr-204 (p < 0.003), and GSK3alphabeta Ser-21/9 (p < 0.01)), and transcription factor pathways (STAT1 Tyr-701 (p < 0.005) and cAMP response element-binding protein Ser-133 (p < 0.01)) showed >20% increases within 90-min postprocurement. Endothelial nitric-oxide synthase Ser-1177 did not change over the time period evaluated with breast or leiomyoma tissue. Treatment with phosphatase or kinase inhibitors alone revealed that tissue kinase pathways are active ex vivo. Combinations of kinase and phosphatase inhibitors appeared to stabilize proteins that exhibited increases in the presence of phosphatase inhibitors alone (ATF-2 Thr-71, SAPK/JNK Thr-183/Tyr-185, STAT1 Tyr-701, JAK1 Tyr-1022/1023, and PAK1/PAK2 Ser-199/204/192/197). This time course study 1) establishes the dynamic nature of specific phosphoproteins in excised tissue, 2) demonstrates augmented phosphorylation in the presence of phosphatase inhibitors, 3) shows that kinase inhibitors block the upsurge in phosphorylation of phosphoproteins, 4) provides a rational strategy for room temperature preservation of proteins, and 5) constitutes a foundation for developing evidence-based tissue procurement guidelines.

Download full-text PDF

Source
http://dx.doi.org/10.1074/mcp.M700596-MCP200DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2559936PMC
October 2008
44 Reads

Publication Analysis

Top Keywords

phosphatase inhibitors
12
tissue procurement
12
tissue
10
stat1 tyr-701
8
time course
8
kinase inhibitors
8
presence phosphatase
8
protein kinase
8
tissue specimens
8
signal pathway
8
kinase
6
time
6
inhibitors
5
protein
5
lung ovary
4
phosphatase
4
endometrium/myometrium metastatic
4
uterus endometrium/myometrium
4
treatment phosphatase
4
ovary uterus
4

Altmetric Statistics

References

(Supplied by CrossRef)

Similar Publications